Xiaoli Li
Impact in
- Nephrology top 10%
- Renal Diseases and Glomerulopathies
-
- Inflammatory Biomarkers in Disease Prognosis
Papers in
- Oncology 11
- Inflammatory Biomarkers in Disease Prognosis 5
- PARP inhibition in cancer therapy 2
-
- Antiplatelet Therapy and Cardiovascular Diseases 5
- Co-authors
- Li Yao (2 shared papers)Zilong Li (2 shared papers)Liping Dong (1 shared paper)Lining Wang (1 shared paper)Yi Jiang (1 shared paper)Linlin Liu (1 shared paper)Yun Liu (1 shared paper)Chunyan Yang (1 shared paper)
- Journals
- Frontiers in Oncology (3 papers)Scientific Reports (2 papers)Frontiers in Immunology (2 papers)Medicine (2 papers)BMC Pulmonary Medicine (1 paper)
- Partner nations
- ChinaSouth Korea
In The Last Decade
Xiaoli Li
39 papers receiving 403 citations
Peers
Comparison fields: 5 of 72
- Nephrology 68
- Oncology 86
- Cardiology and Cardiovascular Medicine 70
- Otorhinolaryngology 15
- Pediatrics, Perinatology and Child Health 34
Countries citing papers authored by Xiaoli Li
This map shows the geographic impact of Xiaoli Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaoli Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaoli Li more than expected).
Fields of papers citing papers by Xiaoli Li
This network shows the impact of papers produced by Xiaoli Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaoli Li. The network helps show where Xiaoli Li may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiaoli Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 42 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2014 | 65 | |
| 2 | 2018 | 40 | |
| 3 | 2019 | 36 | |
| 4 | 2018 | 31 | |
| 5 | 2019 | 22 | |
| 6 | 2013 | 20 | |
| 7 | 2012 | 19 | |
| 8 | 2017 | 17 | |
| 9 | 2020 | 16 | |
| 10 | 2014 | 15 | |
| 11 | 2021 | 15 | |
| 12 | 2013 | 14 | |
| 13 | 2023 | 11 | |
| 14 | 2011 | 8 | |
| 15 | 2024 | 8 | |
| 16 | 2021 | 7 | |
| 17 | 2022 | 7 | |
| 18 | 2023 | 7 | |
| 19 | 2019 | 6 | |
| 20 | 2021 | 6 |
About Xiaoli Li
Xiaoli Li is a scholar working on Oncology, Cardiology and Cardiovascular Medicine, Nephrology, Hematology and Rheumatology, having authored 42 papers that have together received 413 indexed citations. Recurring topics across this work include Inflammatory Biomarkers in Disease Prognosis (5 papers), Antiplatelet Therapy and Cardiovascular Diseases (5 papers), Lung Cancer Treatments and Mutations (2 papers), Rheumatoid Arthritis Research and Therapies (2 papers), Renal Diseases and Glomerulopathies (2 papers), Autoimmune and Inflammatory Disorders Research (2 papers), Traditional Chinese Medicine Analysis (2 papers) and PARP inhibition in cancer therapy (2 papers). The work is most often cited by research in Nephrology (68 citations), Oncology (86 citations), Cardiology and Cardiovascular Medicine (70 citations), Otorhinolaryngology (15 citations) and Pediatrics, Perinatology and Child Health (34 citations). Xiaoli Li has collaborated with scholars based in China and South Korea. Frequent co-authors include Li Yao, Zilong Li, Liping Dong, Lining Wang, Yi Jiang, Linlin Liu, Yun Liu, Chunyan Yang, Qiaozhi Yang and Jian Jing Cao. Their work appears in journals such as Frontiers in Oncology, Scientific Reports, Frontiers in Immunology, Medicine and BMC Pulmonary Medicine.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.